Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_assertion type Assertion NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_head.
- NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_assertion wasGeneratedBy ECO_0000203 NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_provenance.
- NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_assertion wasDerivedFrom befree-20140225 NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_provenance.
- NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_assertion SIO_000772 19920204 NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_provenance.
- NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_assertion evidence source_evidence_literature NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_provenance.
- NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_provenance.